Revolutionary Dermatology Alliance: Medicxi Unifies 6 Biotechs, Secures $100M Funding
Medicxi, a London-based venture capital firm, is merging six dermatology biotechs into one entity called Alys Pharmaceuticals. The combined company will have a multi-platform pipeline focused on immuno-dermatology, with a dozen active